Khan A L, Larsen F, Heys S D, Eremin O
Department of Surgery, University of Aberdeen, Aberdeen, Foresterhill, AB9 2ZD, UK.
Eur J Surg Oncol. 1999 Dec;25(6):574-9. doi: 10.1053/ejso.1999.0709.
Acute phase reactants (APRs) are believed to play an important biological role in trauma, sepsis and malignant disease. We have investigated the induction of the APR, C-reactive protein (CRP), by the biological response modifier, polyadenylic-polyuridylic acid (PAPU) during the peri-operative period.
Twenty post-menopausal women with breast cancer undergoing mastectomy were randomized into a double blind, placebo-controlled, parallel group pilot study. PAPU (150 mg) or placebo was given intravenously the day prior to surgery (D -1), the day of surgery (D 0) and post-operatively on days (D 1, 3, 5, 7 and 14). Blood samples were collected on eight different days (D -2, -1, 0, 1, 2, 4, 6 and 18). CRP was significantly elevated in the PAPU group (P<0.05) on days 2 and 4, when compared with patients receiving placebo. The serum levels of cytokines believed to induce hepatic APRs, were also measured.
The serum concentration of IL-6 was elevated on days 1, 2, 4 and 6 (P<0.05), TNF- alpha and IL-1 beta levels were increased on days 1 and 2 (P<0.05), respectively, while the serum level of soluble interleukin-2 receptor (sIL-2R) was elevated above the baseline on days 0, 2, 4, 6 and 18 in the PAPU group, when compared with the baseline.
This modulation of acute phase response may have important implications for patients with cancer undergoing surgery.
急性期反应物(APRs)被认为在创伤、脓毒症和恶性疾病中发挥重要的生物学作用。我们研究了生物反应调节剂聚腺苷酸-聚尿苷酸(PAPU)在围手术期对急性期反应物C反应蛋白(CRP)的诱导作用。
20例接受乳房切除术的绝经后乳腺癌妇女被随机分为一项双盲、安慰剂对照、平行组的初步研究。在手术前一天(D -1)、手术当天(D 0)以及术后第1、3、5、7和14天静脉给予PAPU(150 mg)或安慰剂。在八个不同时间点(D -2、-1、0、1、2、4、6和18)采集血样。与接受安慰剂的患者相比,PAPU组在第2天和第4天CRP显著升高(P<0.05)。还检测了被认为可诱导肝脏急性期反应物的细胞因子的血清水平。
IL-6的血清浓度在第1、2、4和6天升高(P<0.05),TNF-α和IL-1β水平分别在第1天和第2天升高(P<0.05),而与基线相比,PAPU组可溶性白细胞介素-2受体(sIL-2R)的血清水平在第0、2、4、6和18天高于基线。
急性期反应的这种调节可能对接受手术的癌症患者具有重要意义。